Emmanouil Panagiotidis, MD, MSc, PhD, FEBNM, is an Assistant Professor of Nuclear Medicine at the University of Thessaly, Greece, and a Consultant in PET/CT and theranostics at the University Hospital of Larissa. He previously served as Consultant Nuclear Medicine Physician at the Royal Liverpool University Hospital (UK) and held an appointment as Senior Lecturer (Honorary) at the University of Liverpool. His earlier UK experience includes posts at the Institute of Nuclear Medicine, UCLH, and Central Manchester University Hospitals. His clinical and academic work focuses on hybrid imaging (PET/CT, PET/MRI, SPECT/CT) and targeted radionuclide therapies, with expertise in prostate cancer (PSMA), neuroendocrine tumors, thyroid cancer, bone imaging, and nuclear cardiology. He has authored more than 50 peer-reviewed publications, serves on the Editorial Board of Nuclear Medicine Communications, and is an active reviewer for leading imaging and endocrinology journals. His research interests include molecular imaging biomarkers, theranostics, radiomics, and AI applications in Nuclear Medicine. He is also extensively involved in undergraduate and postgraduate education and has received multiple national awards for research excellence.